Post-earnings recap
Reported
Thu, Nov 6, 2025
EPS actual
$-0.22
EPS est.
$-0.27
EPS surprise
+18.52%
1-day move
-3.63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report shows that 10X Genomics Inc exceeded expectations on EPS, which is a positive sign. However, the stock fell by 3.63% after the announcement, likely due to a lack of revenue data and concerns about market challenges. Investors may be cautious as management did not provide guidance for the upcoming quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.22 | N/A | +18.52% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed caution regarding current market conditions. They highlighted the importance of strategic investments for future growth.
Management acknowledged ongoing challenges in the market.
They emphasized a focus on long-term growth despite short-term pressures.